![Karin Ilg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karin Ilg
Profile
Dr. Karin Ilg is Chief Technology Officer at Malcisbo AG.
She received her undergraduate degree from the University of Regensburg.
Former positions of Karin Ilg
Companies | Position | End |
---|---|---|
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Training of Karin Ilg
University of Regensburg | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Karin Ilg